- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
JAMA Study: Readmissions Are Preventable
Despite literature stating otherwise, a new study finds that readmissions are indeed preventable, research published today in The Journal of the American Medical Association (JAMA) suggests.
Researchers analyzed patients with ST-segment elevation myocardial infarction (STEMI) in 15 counties and found that heart attack patients in the United States have higher readmission rates than other countries (14.5% in the United States compared to 9.9% elsewhere). Health reform advocates recently have targeted STEMI patients as a metric of care and an area for cost savings, according to a JAMA press release.
"Our analysis shows that readmission may be preventable because rates are nearly one-third lower in other countries, suggesting that the U.S. health care system has features that can be modified to decrease readmission rates," the study states. "Understanding these international differences may provide important insight into reducing such rates, particularly in the United States."
Beginning in 2013, hospitals will be penalized for high readmission rates under the Hospital Readmissions Reduction Program.
Read the full story at: http://tinyurl.com/8a2rykk
Source: FierceHealthcare
Understanding How Fitness Affects Digestive Diseases
April 18th 2025Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk, and relieve constipation, while intense workouts may backfire, causing reflux, GI bleeding, or gut barrier disruption.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
